Alterations of LXRα and LXRβ expression in the hypothalamus of glucose-intolerant rats

Journal of Endocrinology

Volumn 215, Issue 1, 2012, Pages 51-58

  Kruse, María Sol ^a   Rey, Mariana ^a   Vega, María Cristina ^a   Coirini, Héctor ^a,b,c  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSIDAD NACIONAL DE SAN JUAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; INSULIN; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; TRIACYLGLYCEROL; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMUNOCYTOCHEMISTRY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOOD GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INSULIN; MALE; MICROSCOPY, CONFOCAL; ORPHAN NUCLEAR RECEPTORS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TRIGLYCERIDES;

EID: 84869205618     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0088     Document Type: Article

References (37)

1. Alberti KG & Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 15 539-553.
2. Alberti KG, Zimmet P & Shaw J 2005 The metabolic syndrome - a new worldwide definition. Lancet 366 1059-1062.
3. Bantubungi K, Prawitt J & Staels B 2011 Control of metabolism by nutrient-regulated nuclear receptors acting in the brain. Journal of Steroid Biochemistry and Molecular Biology 130 126-137.
4. Baranowski M 2008 Biological role of liver X receptors. Journal of Physiology and Pharmacology 59 (Suppl 7) 31-55.
5. Bjorkhem I, Lutjohann D, Diczfalusy U, Stahle L, Ahlborg G & Wahren J 1998 Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. Journal of Lipid Research 39 1594-1600.
6. Cao G, Liang Y, Broderick CL, Oldham BA, Beyer TP, Schmidt RJ, Zhang Y, Stayrook KR, Suen C, Otto KA et al. 2003 Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. Journal of Biological Chemistry 278 1131-1136.
7. Choe SS, Choi AH, Lee JW, Kim KH, Chung JJ, Park J, Lee KM, Park KG, Lee IK & Kim JB 2007 Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptormediated lipotoxicity in pancreatic beta-cells. Diabetes 56 1534-1543.
8. Coirini H, Marusic ET, De Nicola AF, Rainbow TC & McEwen BS 1983 Identification of mineralocorticoid binding sites in rat brain by competition studies and density gradient centrifugation. Neuroendocrinology 37 354-360.
9. Commerford SR, Vargas L, Dorfman SE, Mitro N, Rocheford EC, Mak PA, Li X, Kennedy P, Mullarkey TL & Saez E 2007 Dissection of the insulinsensitizing effect of liver X receptor ligands. Molecular Endocrinology 21 3002-3012.
10. Cozzone D, Debard C, Dif N, Ricard N, Disse E, Vouillarmet J, Rabasa-Lhoret R, Laville M, Pruneau D, Rieusset J et al. 2006 Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells. Diabetologia 49 990-999.
11. Cruz-Garcia L, Sanchez-Gurmaches J, Gutierrez J & Navarro I 2011 Regulation of LXR by fatty acids, insulin, growth hormone and tumor necrosis factor-a in rainbow trout myocytes. Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology 160 125-136.
12. Denechaud PD, Bossard P, Lobaccaro JM, Millatt L, Staels B, Girard J & Postic C 2008 ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. Journal of Clinical Investigation 118 956-964.
13. Dowell P, Hu Z & Lane MD 2005 Monitoring energy balance: metabolites of fatty acid synthesis as hypothalamic sensors. Annual Review of Biochemistry 74 515-534.
14. Kase ET, Thoresen GH, Westerlund S, Hojlund K, Rustan AC & Gaster M 2007 Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals. Diabetologia 50 2171-2180.
15. Kruse MS, Premont J, Krebs MO & Jay TM 2009a Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 19 296-304.
16. Kruse MS, Rey M, Barutta J & Coirini H 2009b Allopregnanolone effects on astrogliosis induced by hypoxia in organotypic cultures of striatum, hippocampus, and neocortex. Brain Research 1303 1-7.
17. Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL & Tontonoz P 2001 Autoregulation of the human liver X receptor a promoter. Molecular and Cellular Biology 21 7558-7568.
18. Laffitte BA, Chao LC, Li J, Walczak R, Hummasti S, Joseph SB, Castrillo A, Wilpitz DC, Mangelsdorf DJ, Collins JL et al. 2003 Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. PNAS 100 5419-5424.
19. Li Y, Bolten C, Bhat BG, Woodring-Dietz J, Li S, Prayaga SK, Xia C & Lala DS 2002 Induction of human liver X receptor a gene expression via an autoregulatory loop mechanism. Molecular Endocrinology 16 506-514.
20. Lin S, Yang Z, Liu H, Tang L & Cai Z 2011 Beyond glucose: metabolic shifts in responses to the effects of the oral glucose tolerance test and the highfructose diet in rats. Molecular BioSystems 7 1537-1548.
21. Luoma PV 2011 Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia. Current Molecular Medicine 11 391-400.
22. Lutjohann D, Breuer O, Ahlborg G, Nennesmo I, Siden A, Diczfalusy U & Bjorkhem I 1996 Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. PNAS 93 9799-9804.
23. Matsumoto S, Hashimoto K, Yamada M, Satoh T, Hirato J & Mori M 2009 Liver X receptor-a regulates proopiomelanocortin (POMC) gene transcription in the pituitary. Molecular Endocrinology 23 47-60.
24. Mitro N, Mak PA, Vargas L, Godio C, Hampton E, Molteni V, Kreusch A & Saez E 2007 The nuclear receptor LXR is a glucose sensor. Nature 445 219-223.
25. Morales JR, Ballesteros I, Deniz JM, Hurtado O, Vivancos J, Nombela F, Lizasoain I, Castrillo A & Moro MA 2008 Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke. Circulation 118 1450-1459.
26. Nilsson M, Stulnig TM, Lin CY, Yeo AL, Nowotny P, Liu ET & Steffensen KR 2007 Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback. Molecular Endocrinology 21 126-137.
27. Ohyama Y, Meaney S, Heverin M, Ekstrom L, Brafman A, Shafir M, Andersson U, Olin M, Eggertsen G, Diczfalusy U et al. 2006 Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes. Journal of Biological Chemistry 281 3810-3820.
28. Schmidt A, Vogel R, Holloway MK, Rutledge SJ, Friedman O, Yang Z, Rodan GA & Friedman E 1999 Transcription control and neuronal differentiation by agents that activate the LXR nuclear receptor family. Molecular and Cellular Endocrinology 155 51-60.
29. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ & Baskin DG 2000 Central nervous system control of food intake. Nature 404 661-671.
30. Sleder J, Chen YD, Cully MD & Reaven GM 1980 Hyperinsulinemia in fructose-induced hypertriglyceridemia in the rat. Metabolism 29 303-305.
31. Stayrook KR, Rogers PM, Savkur RS, Wang Y, Su C, Varga G, Bu X, Wei T, Nagpal S, Liu XS et al. 2008 Regulation of human 3a-hydroxysteroid dehydrogenase (AKR1C4) expression by the liver X receptor a. Molecular Pharmacology 73 607-612.
32. Tian L, Luo N, Klein RL, Chung BH, GarveyWT & Fu Y 2009 Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis 202 152-161.
33. Tobin KA, Ulven SM, Schuster GU, Steineger HH, Andresen SM, Gustafsson JA & Nebb HI 2002 Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. Journal of Biological Chemistry 277 10691-10697.
34. Ulven SM, Dalen KT, Gustafsson JA & Nebb HI 2004 Tissue-specific autoregulation of the LXRα gene facilitates induction of apoE in mouse adipose tissue. Journal of Lipid Research 45 2052-2062.
35. Whitney KD, Watson MA, Goodwin B, Galardi CM, Maglich JM, Wilson JG, Willson TM, Collins JL & Kliewer SA 2001 Liver X receptor (LXR) regulation of the LXRα gene in human macrophages. Journal of Biological Chemistry 276 43509-43515.
36. Whitney KD, Watson MA, Collins JL, Benson WG, Stone TM, Numerick MJ, Tippin TK, Wilson JG, Winegar DA & Kliewer SA 2002 Regulation of cholesterol homeostasis by the liverX receptors in the central nervous system. Molecular Endocrinology 16 1378-1385.
37. Zavaroni I, Sander S, Scott S & Reaven GM 1980 Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 29 970-973.